Cargando…

Extra- and Intra-Cellular Mechanisms of Hepatic Stellate Cell Activation

Hepatic fibrosis is characterized by the pathological accumulation of extracellular matrix (ECM) in the liver resulting from the persistent liver injury and wound-healing reaction induced by various insults. Although hepatic fibrosis is considered reversible after eliminating the cause of injury, ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Yufei, Zeng, Jiefei, Xing, Linhao, Li, Changyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391653/
https://www.ncbi.nlm.nih.gov/pubmed/34440218
http://dx.doi.org/10.3390/biomedicines9081014
_version_ 1783743325057056768
author Yan, Yufei
Zeng, Jiefei
Xing, Linhao
Li, Changyong
author_facet Yan, Yufei
Zeng, Jiefei
Xing, Linhao
Li, Changyong
author_sort Yan, Yufei
collection PubMed
description Hepatic fibrosis is characterized by the pathological accumulation of extracellular matrix (ECM) in the liver resulting from the persistent liver injury and wound-healing reaction induced by various insults. Although hepatic fibrosis is considered reversible after eliminating the cause of injury, chronic injury left unchecked can progress to cirrhosis and liver cancer. A better understanding of the cellular and molecular mechanisms controlling the fibrotic response is needed to develop novel clinical strategies. It is well documented that activated hepatic stellate cells (HSCs) is the most principal cellular players promoting synthesis and deposition of ECM components. In the current review, we discuss pathways of HSC activation, emphasizing emerging extra- and intra-cellular signals that drive this important cellular response to hepatic fibrosis. A number of cell types and external stimuli converge upon HSCs to promote their activation, including hepatocytes, liver sinusoidal endothelial cells, macrophages, cytokines, altered ECM, hepatitis viral infection, enteric dysbiosis, lipid metabolism disorder, exosomes, microRNAs, alcohol, drugs and parasites. We also discuss the emerging signaling pathways and intracellular events that individually or synergistically drive HSC activation, including TGFβ/Smad, Notch, Wnt/β-catenin, Hedgehog and Hippo signaling pathways. These findings will provide novel potential therapeutic targets to arrest or reverse fibrosis and cirrhosis.
format Online
Article
Text
id pubmed-8391653
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83916532021-08-28 Extra- and Intra-Cellular Mechanisms of Hepatic Stellate Cell Activation Yan, Yufei Zeng, Jiefei Xing, Linhao Li, Changyong Biomedicines Review Hepatic fibrosis is characterized by the pathological accumulation of extracellular matrix (ECM) in the liver resulting from the persistent liver injury and wound-healing reaction induced by various insults. Although hepatic fibrosis is considered reversible after eliminating the cause of injury, chronic injury left unchecked can progress to cirrhosis and liver cancer. A better understanding of the cellular and molecular mechanisms controlling the fibrotic response is needed to develop novel clinical strategies. It is well documented that activated hepatic stellate cells (HSCs) is the most principal cellular players promoting synthesis and deposition of ECM components. In the current review, we discuss pathways of HSC activation, emphasizing emerging extra- and intra-cellular signals that drive this important cellular response to hepatic fibrosis. A number of cell types and external stimuli converge upon HSCs to promote their activation, including hepatocytes, liver sinusoidal endothelial cells, macrophages, cytokines, altered ECM, hepatitis viral infection, enteric dysbiosis, lipid metabolism disorder, exosomes, microRNAs, alcohol, drugs and parasites. We also discuss the emerging signaling pathways and intracellular events that individually or synergistically drive HSC activation, including TGFβ/Smad, Notch, Wnt/β-catenin, Hedgehog and Hippo signaling pathways. These findings will provide novel potential therapeutic targets to arrest or reverse fibrosis and cirrhosis. MDPI 2021-08-14 /pmc/articles/PMC8391653/ /pubmed/34440218 http://dx.doi.org/10.3390/biomedicines9081014 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Yan, Yufei
Zeng, Jiefei
Xing, Linhao
Li, Changyong
Extra- and Intra-Cellular Mechanisms of Hepatic Stellate Cell Activation
title Extra- and Intra-Cellular Mechanisms of Hepatic Stellate Cell Activation
title_full Extra- and Intra-Cellular Mechanisms of Hepatic Stellate Cell Activation
title_fullStr Extra- and Intra-Cellular Mechanisms of Hepatic Stellate Cell Activation
title_full_unstemmed Extra- and Intra-Cellular Mechanisms of Hepatic Stellate Cell Activation
title_short Extra- and Intra-Cellular Mechanisms of Hepatic Stellate Cell Activation
title_sort extra- and intra-cellular mechanisms of hepatic stellate cell activation
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391653/
https://www.ncbi.nlm.nih.gov/pubmed/34440218
http://dx.doi.org/10.3390/biomedicines9081014
work_keys_str_mv AT yanyufei extraandintracellularmechanismsofhepaticstellatecellactivation
AT zengjiefei extraandintracellularmechanismsofhepaticstellatecellactivation
AT xinglinhao extraandintracellularmechanismsofhepaticstellatecellactivation
AT lichangyong extraandintracellularmechanismsofhepaticstellatecellactivation